CD274 and neoplasm: Studies have demonstrated that PD-L1 is expressed in tumour cells in approximately 63% of UC-OGCP patients, and PD-L1 expression is strongly associated with a poor prognosis, potentially offering valuable insights for the development and optimization of treatment strategies (29).